The war of words between Echo Therapeutics (NSDQ:ECTE) and Platinum Equity resumed today with Echo claiming that the activist investor may have run afoul of federal securities laws with a preliminary proxy statement.
Philadelphia-based Echo has suspended operations until it can find outside investment, but has rejected terms for an infusion offered by Platinum Equity. Today the company’s board urged stockholders to discard any proxy solicitation materials they receive from Platinum.
Help employers find you! Check out all the jobs and post your resume.
